Rao K V, Kjellstrand C M
Clin Exp Dial Apheresis. 1983;7(1-2):127-43. doi: 10.3109/08860228309076044.
Post transplant acute tubular necrosis (ATN) is responsible for approximately 90% of acute renal failure episodes occurring within the first few weeks following renal transplantation. This phenomenon is observed in 34% of cadaver transplant recipients and 9% of those with live donor kidneys. Although the exact cause of post transplant ATN remains unknown, the following factors are thought to be associated with a higher incidence of ATN: 1) donor hypotension, 2) prolonged "warm ischemia time", 3) increased vascular resistance with poor perfusate flow, 4) presence of "ligandin" or excess lactate in the renal perfusate, 5) reduced allograft blood flow, 6) cold lymphocytotoxins in the patient's serum and 7) administration of nephrotoxic drugs particularly to the hypovolemic graft recipients. Therapeutic maneuvers such as hydration of the donors and recipients, harvesting the kidneys from heart beating cadavers, donor pretreatment with massive doses of corticosteroids and alpha-adrenergic blocking agents and warming of the graft immediately after vascular anastomosis, seem to reduce the incidence of ATN. Since the management differs significantly, post transplant ATN has to be distinguished from other causes of acute renal failure such as the renal artery thrombosis, hyperacute rejection and obstruction of the urinary tract. The tests which are of use in the differential diagnosis include, 131-I Hippuran renogram, transplant ultrasound, renal angiogram, retrograde pyelogram and renal transplant biopsy. Patients with established ATN should undergo every other day dialysis, under low dose or regional heparinization, until the creatinine clearance improves to 20 ml/min. The dose of azathioprine has to be reduced to prevent bone marrow toxicity. Even though there are short term disadvantages, the post transplant ATN does not appear to exert any detrimental effects in the long run. However, this issue remains controversial in the published reports.
移植后急性肾小管坏死(ATN)约占肾移植后最初几周内发生的急性肾衰竭病例的90%。在34%的尸体肾移植受者和9%的活体供肾受者中观察到这种现象。虽然移植后ATN的确切病因尚不清楚,但以下因素被认为与ATN的较高发病率相关:1)供体低血压;2)延长的“热缺血时间”;3)血管阻力增加且灌注液流量不佳;4)肾灌注液中存在“配体蛋白”或过量乳酸;5)移植肾血流量减少;6)患者血清中的冷淋巴细胞毒素;7)对低血容量的移植受者使用肾毒性药物。诸如对供体和受体进行水化、从心跳骤停的尸体获取肾脏、用大剂量皮质类固醇和α-肾上腺素能阻滞剂对供体进行预处理以及血管吻合后立即对移植物进行复温等治疗措施,似乎可降低ATN的发病率。由于处理方式差异显著,移植后ATN必须与急性肾衰竭的其他病因如肾动脉血栓形成、超急性排斥反应和尿路梗阻相区分。用于鉴别诊断的检查包括131-I马尿酸肾图、移植肾超声、肾血管造影、逆行肾盂造影和肾移植活检。确诊为ATN的患者应每隔一天进行透析,采用低剂量或局部肝素化,直至肌酐清除率提高至20 ml/分钟。必须减少硫唑嘌呤的剂量以防止骨髓毒性。尽管存在短期不利因素,但从长远来看,移植后ATN似乎不会产生任何有害影响。然而,这一问题在已发表的报告中仍存在争议。